Home Cart 0 Sign in  

[ CAS No. 5751-20-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 5751-20-2
Chemical Structure| 5751-20-2
Structure of 5751-20-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5751-20-2 ]

Related Doc. of [ 5751-20-2 ]

Alternatived Products of [ 5751-20-2 ]

Product Details of [ 5751-20-2 ]

CAS No. :5751-20-2 MDL No. :MFCD00047373
Formula : C5H6N2OS Boiling Point : -
Linear Structure Formula :- InChI Key :UYHSQVMHSFXUOA-UHFFFAOYSA-N
M.W : 142.18 Pubchem ID :79823
Synonyms :
2-Methylthio-4-pyrimidone

Calculated chemistry of [ 5751-20-2 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.2
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 36.58
TPSA : 71.05 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.01 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.36
Log Po/w (XLOGP3) : 0.22
Log Po/w (WLOGP) : 0.49
Log Po/w (MLOGP) : 0.0
Log Po/w (SILICOS-IT) : 1.63
Consensus Log Po/w : 0.74

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.29
Solubility : 7.33 mg/ml ; 0.0516 mol/l
Class : Very soluble
Log S (Ali) : -1.27
Solubility : 7.61 mg/ml ; 0.0535 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.03
Solubility : 1.32 mg/ml ; 0.00929 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.68

Safety of [ 5751-20-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5751-20-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5751-20-2 ]
  • Downstream synthetic route of [ 5751-20-2 ]

[ 5751-20-2 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 5751-20-2 ]
  • [ 49844-90-8 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 6, p. 1146 - 1157
[2] Patent: WO2018/92034, 2018, A1, . Location in patent: Paragraph 0075
  • 2
  • [ 5751-20-2 ]
  • [ 49844-90-8 ]
Reference: [1] Yakugaku Zasshi, 1949, vol. 69, p. 491[2] Chem.Abstr., 1950, p. 3456
[3] Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1982, vol. 36, # 1 B, p. 15 - 18
  • 3
  • [ 5751-20-2 ]
  • [ 49844-90-8 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1989, p. 1499 - 1506
  • 4
  • [ 5751-20-2 ]
  • [ 63810-78-6 ]
Reference: [1] Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1982, vol. 36, # 1 B, p. 15 - 18
[2] Patent: CN107488175, 2017, A,
  • 5
  • [ 5751-20-2 ]
  • [ 81560-03-4 ]
YieldReaction ConditionsOperation in experiment
87% With N-Bromosuccinimide In dichloromethane for 6 h; Reflux Step 2, Preparation of 5-bromo-2-methylthio-4-pyrimidinone: Take 142 g of 2-methylthio-4-pyrimidinone, dissolve in 500 ml of methylene chloride, add NBS 190 g, reflux for 6 hours, After the reaction is completed, cool to room temperature, filter, wash the filtrate, organicThe phase was dried and recrystallized on an ice bath to give 190 g of a pale yellow solid in a yield of 87percent.
62% at 0 - 20℃; for 16 h; (EX-6B) A solution of EX-6A (74.0 g, 520.5 mmol) in glacial acetic acid (2275 mL) was cooled to 0° C. with an ice bath and treated with Br2. The reaction mixture was allowed to warm to room temperature, and to stir for 16 h. A yellow precipitate formed which was filtered and washed with ether three times. 97.2 g of EX-6B was isolated in 62percent yield.
45% With bromine In acetic acid at 20℃; for 0.5 h; To a solution containing 2.0 g (14 mmol) of 2- (methylthio) pyrimidin-4(3H)-one in 10 ml of acetic acid under a nitrogen atmosphere was added 1.04 ml (14 mmol) of bromine in 2 ml acetic acid. The reaction was allowed to stir at room temperature for 30 min. The precipitated product was filtered, washed with acetic acid and suspended in hot acetic acid- To this suspention was added 0.2 ml bromine in 1ml acetic acid. The product was collected, washed with acetic acid and recrystallized from ethanol to yield 1.4 g (45 percent) of product. 1H NMR (CD30D) 5: 2. 61 (s, 3H) , 8.29 (s, 1H).
Reference: [1] Patent: CN107488175, 2017, A, . Location in patent: Paragraph 0008; 0010
[2] Acta Chemica Scandinavica, Series B: Organic Chemistry and Biochemistry, 1982, vol. 36, # 1 B, p. 15 - 18
[3] Patent: US6653316, 2003, B1, . Location in patent: Page/Page column 117-118
[4] Patent: WO2005/99688, 2005, A2, . Location in patent: Page/Page column 173
[5] Journal of the American Chemical Society, 1948, vol. 70, p. 1753,1755
[6] Patent: WO2011/130908, 2011, A1, . Location in patent: Page/Page column 54-55
[7] Patent: WO2011/133444, 2011, A1, . Location in patent: Page/Page column 53-54
  • 6
  • [ 5751-20-2 ]
  • [ 98-80-6 ]
  • [ 56734-10-2 ]
Reference: [1] Synlett, 2012, vol. 23, # 9, p. 1305 - 1308
  • 7
  • [ 110-91-8 ]
  • [ 5751-20-2 ]
  • [ 19810-79-8 ]
YieldReaction ConditionsOperation in experiment
49% at 145℃; for 2 h; 2B) 2-MORPHOLIN-4-VL-PYRIMIDIN-4-OL To the 2-thiomethyluracil (4.0 g, 0.0281 mol) is added morpholine (3.05 G, 0.035 MOL). The mixture is heated to 145°C for 2 hours then cooled to room temperature. The solid is crystallized from ethanol. White needles are collected (2.0 g). Second crop of crystals form approximately 0.50 g (49percent). M+H = 181. 'H NMR (CDC13) ; 612. 1 (bs, 1H), 7.85 (d, 1H), 5.79 (d, 1H), 3.75 (m, 8H).
Reference: [1] Patent: WO2005/28444, 2005, A1, . Location in patent: Page/Page column 49
  • 8
  • [ 37595-74-7 ]
  • [ 5751-20-2 ]
  • [ 456-64-4 ]
  • [ 154499-77-1 ]
Reference: [1] Heterocycles, 1994, vol. 37, # 1, p. 501 - 514
  • 9
  • [ 5751-20-2 ]
  • [ 97229-11-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 6, p. 1146 - 1157
[2] Patent: WO2018/92034, 2018, A1,
  • 10
  • [ 5751-20-2 ]
  • [ 99469-85-9 ]
Reference: [1] Patent: WO2012/52948, 2012, A1,
  • 11
  • [ 5751-20-2 ]
  • [ 5720-07-0 ]
  • [ 148990-17-4 ]
Reference: [1] Synlett, 2012, vol. 23, # 9, p. 1305 - 1308
  • 12
  • [ 5751-20-2 ]
  • [ 148990-17-4 ]
Reference: [1] Heterocycles, 1994, vol. 37, # 1, p. 501 - 514
[2] Heterocycles, 1994, vol. 37, # 1, p. 501 - 514
  • 13
  • [ 5751-20-2 ]
  • [ 959236-97-6 ]
YieldReaction ConditionsOperation in experiment
83% With phosphorus(V) oxybromide In acetonitrile at 80℃; for 5 h; To a stirred solution of 2-(methylthio)pyrimidin-4(3H)-one (5 g, 35.21 mmol, leq) in ACN (lOOmL) was added POBr3 (12.1 g, 42.3 mmol, 1.2 eq) at RT, then the reaction mixture was heated to 80°C for 5h. Monitored by TLC, the reaction mixture was cooled to RT and quenched in ice cold water then extracted with EtOAc (2X100mL). The combined organic layer was dried over Na2SC>4 and concentrated to crude compound. The crude compound was purified by column chromatography (silica gel, 100-200 mesh) using 0-10percent EtOAc in pet ether as eluent to afford 4- bromo-2-(methylthio)pyrimidine (6g, 83percent) as off-white solid. LCMS: [M+H]+ 204.9.
Reference: [1] Patent: WO2017/147700, 2017, A1, . Location in patent: Paragraph 001094
  • 14
  • [ 5751-20-2 ]
  • [ 1208538-52-6 ]
Reference: [1] Patent: WO2017/147700, 2017, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 5751-20-2 ]

Amides

Chemical Structure| 20651-30-3

[ 20651-30-3 ]

5-Methyl-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.85

Chemical Structure| 54030-56-7

[ 54030-56-7 ]

6-Amino-3-methyl-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.84

Chemical Structure| 81560-03-4

[ 81560-03-4 ]

5-Bromo-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.80

Chemical Structure| 89487-99-0

[ 89487-99-0 ]

4-Hydroxy-2-(methylthio)pyrimidine-5-carbonitrile

Similarity: 0.78

Chemical Structure| 39008-28-1

[ 39008-28-1 ]

5,6-Diamino-3-methyl-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.72

Sulfides

Chemical Structure| 20651-30-3

[ 20651-30-3 ]

5-Methyl-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.85

Chemical Structure| 54030-56-7

[ 54030-56-7 ]

6-Amino-3-methyl-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.84

Chemical Structure| 81560-03-4

[ 81560-03-4 ]

5-Bromo-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.80

Chemical Structure| 89487-99-0

[ 89487-99-0 ]

4-Hydroxy-2-(methylthio)pyrimidine-5-carbonitrile

Similarity: 0.78

Chemical Structure| 53554-29-3

[ 53554-29-3 ]

Ethyl 2-(methylthio)-6-oxo-1,6-dihydropyrimidine-5-carboxylate

Similarity: 0.67

Related Parent Nucleus of
[ 5751-20-2 ]

Pyrimidines

Chemical Structure| 20651-30-3

[ 20651-30-3 ]

5-Methyl-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.85

Chemical Structure| 54030-56-7

[ 54030-56-7 ]

6-Amino-3-methyl-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.84

Chemical Structure| 81560-03-4

[ 81560-03-4 ]

5-Bromo-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.80

Chemical Structure| 89487-99-0

[ 89487-99-0 ]

4-Hydroxy-2-(methylthio)pyrimidine-5-carbonitrile

Similarity: 0.78

Chemical Structure| 39008-28-1

[ 39008-28-1 ]

5,6-Diamino-3-methyl-2-(methylthio)pyrimidin-4(3H)-one

Similarity: 0.72